About the Event Producer, Jacqueline Lopez:
Jacqueline’s life-partner, Michael was diagnosed with two types of cancer, and the stress from the diagnosis and the ensuing traditional medical approach was taking a toll on their family’s health and well-being.
In 2017 Michael’s health hit new lows which made living a normal life nearly impossible.
In desperation, they sought out assistance to experience entheogens as a means to cope with end-of-life-anxieties. This lead Jacqueline and Michael to discover the research, such as that backed by prestigious organization such as Johns Hopkins University, correlating “earlier scientific findings that psilocybin administered in a clinical setting can produce mystical-type experiences that have substantial and sustained personal meaning and spiritual significance” (Griffiths, 2008).
They decided to share a guided ‘tour’ with Psilocybin, and it was a life changing experience.
The intensely mystical and spiritual experience was so dramatic that it opened them up to a new way of being and gave them a new sense of purpose to serve others. It changed their personality to be less materialistic and more balanced and turned them from being cynical towards organized religion to feeling connected to something greater than themselves.
Because of this new awareness, Jacqueline was inspired to produce EntheoMedicine Event to create a local forum where people could learn from each other and share their experiences with Entheogens and psychedelics.
Jacqueline’s strength and experience come from her background in entrepreneurial skills she developed throughout her career combined with a bigger and deeper view of humanity and the world. As a speaker, she inspires everyone to question what he or she has been told by society, to commit to evolving as a conscious being, and to form his or her own opinions.
She believes that guided use of entheogen is another tool, like deep introspection and presence, to be utilized for our evolution.
Michael is currently using RSO (Ralph Simpson Oil – cannabis suppository) for prostate cancer, results of this treatment is still in an early stage.